http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107837296-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f808fd9a0e13c70c06abfccdb70dc709 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-481 |
| filingDate | 2017-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828c0be3da139a0ac3ddd6418776583e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a09e080844284044e775556cfd8887a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_645dc40210a12b84c6556924f115500e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a59fe028e124545aa22aa8ff3775efe8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3546ae72d46fe96238827b3296d4533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef5cac82587f736a6a773e36fe7ac56c |
| publicationDate | 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107837296-A |
| titleOfInvention | Compound Chinese Medicine for Treating Qi Deficiency and Blood Stasis Syndrome in Apoplexy |
| abstract | The invention discloses a compound traditional Chinese medicine for treating apoplexy with qi deficiency and blood stasis syndrome, which is mainly prepared from the following medicinal materials: Phnom Penh leech, tuyuan, earthworm and astragalus. The medicine adopts Phnom Penh leech, a natural animal medicine unique to Guangxi, which has a strong effect of promoting blood circulation and removing blood stasis, to achieve the effects of promoting blood circulation and removing blood stasis, replenishing qi and dredging collaterals. A large number of experimental studies have proved that the present invention has obvious antithrombotic effect and anticoagulant effect in vivo, can significantly improve microcirculation disturbance, and has certain blood lipid lowering effect on hyperlipidemia, with definite curative effect. Accordingly, the inventor combined the modern scientific preparation technology to make a pure Chinese medicine compound preparation—Zhixuetong enteric-coated capsules. Clinical practice shows that the present invention has good clinical curative effect in the treatment of stroke due to qi deficiency and blood stasis syndrome, high cure rate, convenient application, high safety, no obvious toxic and side effects, few and mild adverse reactions, and no severe toxic and side effects such as bleeding and thrombocytopenia. . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113413409-A |
| priorityDate | 2017-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.